Role of FGF23 in vitamin D and phosphate metabolism: Implications in chronic kidney disease
Tóm tắt
Từ khóa
Tài liệu tham khảo
Antoniucci, 2006, Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men, J. Clin. Endocrinol. Metab., 91, 3144, 10.1210/jc.2006-0021
Bai, 2004, Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders, Endocrinology, 145, 5269, 10.1210/en.2004-0233
Beckman, 1996, Human 25-hydroxyvitamin D3-24-hydroxylase, a multicatalytic enzyme, Biochemistry, 35, 8465, 10.1021/bi960658i
Ben-Dov, 2007, The parathyroid is a target organ for FGF23 in rats, J. Clin. Invest., 117, 4003
Ben-Dov, 2007, The parathyroid is a target organ for FGF23 in rats, J. Clin. Invest., 117, 4003
Benet-Pages, 2005, An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia, Hum. Mol. Genet., 14, 385, 10.1093/hmg/ddi034
Block, 2004, Mineral metabolism, mortality, and morbidity in maintenance hemodialysis, J. Am. Soc. Nephrol., 15, 2208, 10.1097/01.ASN.0000133041.27682.A2
Brown, 2009, Hypophosphatemia with elevations in serum fibroblast growth factor 23 in a child with Jansen's metaphyseal chondrodysplasia, J. Clin. Endocrinol. Metab., 94, 17, 10.1210/jc.2008-0220
Burnett, 2006, Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women, J. Bone Miner. Res., 21, 1187, 10.1359/jbmr.060507
Clemens, 2011, The osteoblast: an insulin target cell controlling glucose homeostasis, J. Bone Miner. Res., 26, 677, 10.1002/jbmr.321
Craver, 2007, Mineral metabolism parameters throughout chronic kidney disease stages 1–5—achievement of K/DOQI target ranges, Nephrol. Dial. Transplant., 22, 1171, 10.1093/ndt/gfl718
Feng, 2006, Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism, Nat. Genet., 38, 1310, 10.1038/ng1905
Ferrari, 2005, Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men, J. Clin. Endocrinol. Metab., 90, 1519, 10.1210/jc.2004-1039
Fliser, 2007, Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study, J. Am. Soc. Nephrol., 18, 2600, 10.1681/ASN.2006080936
Fukumoto, 2002, Fibroblast growth factor-23 is the phosphaturic factor in tumor-induced osteomalacia and may be phosphatonin, Curr. Opin. Nephrol. Hypertens., 11, 385, 10.1097/00041552-200207000-00003
Galitzer, H., Ben-Dov, I.Z., Silver, J., and Naveh-Many, T. Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease. Kidney Int. 77: 211–218.
Goebel, 2009, FGF23 is a putative marker for bone healing and regeneration, J. Orthop. Res., 10.1002/jor.20857
Gutierrez, 2005, Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease, J. Am. Soc. Nephrol., 16, 2205, 10.1681/ASN.2005010052
Gutierrez, 2008, Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis, N. Engl. J. Med., 359, 584, 10.1056/NEJMoa0706130
Hasegawa, 2010, Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease, Kidney Int., 78, 975, 10.1038/ki.2010.313
Helvig, 2010, Dysregulation of renal vitamin D metabolism in the uremic rat, Kidney Int., 78, 463, 10.1038/ki.2010.168
Hirai, 2011, Parathyroid hormone/parathyroid hormone-related protein receptor signaling is required for maintenance of the growth plate in postnatal life, Proc. Natl. Acad. Sci. U. S. A., 108, 191, 10.1073/pnas.1005011108
Hoenderop, 2004, Regulation of gene expression by dietary Ca2+ in kidneys of 25-hydroxyvitamin D3-1 alpha-hydroxylase knockout mice, Kidney Int., 65, 531, 10.1111/j.1523-1755.2004.00402.x
Hu, 2010, Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule, FASEB J., 10.1096/fj.10-154765
Imanishi, 2004, FGF-23 in patients with end-stage renal disease on hemodialysis, Kidney Int., 65, 1943, 10.1111/j.1523-1755.2004.00604.x
Isakova, 2010, Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease, Nephrol. Dial. Transplant., 26, 584, 10.1093/ndt/gfq419
Jean, 2009, Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences, Nephrol. Dial. Transplant., 24, 948, 10.1093/ndt/gfn571
Kato, 2006, Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation, J. Biol. Chem., 281, 18370, 10.1074/jbc.M602469200
Kawata, 2007, Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism, J. Am. Soc. Nephrol., 18, 2683, 10.1681/ASN.2006070783
Kobayashi, 2006, Expression of FGF23 is correlated with serum phosphate level in isolated fibrous dysplasia, Life Sci., 78, 2295, 10.1016/j.lfs.2005.09.052
Kobayashi, 2006, Regulation of plasma fibroblast growth factor 23 by calcium in primary hyperparathyroidism, Eur. J. Endocrinol., 154, 93, 10.1530/eje.1.02053
Koh, 2001, Severely reduced production of klotho in human chronic renal failure kidney, Biochem. Biophys. Res. Commun., 280, 1015, 10.1006/bbrc.2000.4226
Kolek, 2005, 1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal–gastrointestinal–skeletal axis that controls phosphate transport, Am. J. Physiol. Gastrointest. Liver Physiol., 289, G1036, 10.1152/ajpgi.00243.2005
Komaba, 2010, FGF23-parathyroid interaction: implications in chronic kidney disease, Kidney Int., 77, 292, 10.1038/ki.2009.466
Kuro-o, 1997, Mutation of the mouse klotho gene leads to a syndrome resembling ageing, Nature, 390, 45, 10.1038/36285
Kurosu, 2006, Regulation of fibroblast growth factor-23 signaling by klotho, J. Biol. Chem., 281, 6120, 10.1074/jbc.C500457200
Larsson, 2005, Fibroblast growth factor-23 mutants causing familial tumoral calcinosis are differentially processed, Endocrinology, 146, 3883, 10.1210/en.2005-0431
Larsson, 2004, Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis, Endocrinology, 145, 3087, 10.1210/en.2003-1768
Larsson, 2003, Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers, Kidney Int., 64, 2272, 10.1046/j.1523-1755.2003.00328.x
Lavi-Moshayoff, 2010, PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop, Am. J. Physiol. Renal Physiol., 299, F882, 10.1152/ajprenal.00360.2010
Li, 2011, Compound deletion of Fgfr3 and Fgfr4 partially rescues the Hyp mouse phenotype, Am. J. Physiol. Endocrinol. Metab., 300, E508, 10.1152/ajpendo.00499.2010
Li, 2010, Compound deletion of FGFR3 and FGFR4 partially rescues the Hyp mouse phenotype, Am. J. Physiol. Endocrinol. Metab., E508
Li, 2004, Immunohistochemical localization of Klotho protein in brain, kidney, and reproductive organs of mice, Cell Struct. Funct., 29, 91, 10.1247/csf.29.91
Liu, 2003, Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX, J. Biol. Chem., 278, 37419, 10.1074/jbc.M304544200
Liu, 2007, How fibroblast growth factor 23 works, J. Am. Soc. Nephrol., 18, 1637, 10.1681/ASN.2007010068
Liu, 2007, Phosphorylated acidic serine-aspartate-rich MEPE-associated motif peptide from matrix extracellular phosphoglycoprotein inhibits phosphate regulating gene with homologies to endopeptidases on the X-chromosome enzyme activity, J. Endocrinol., 192, 261, 10.1677/joe.1.07059
Liu, 2009, Novel regulators of Fgf23 expression and mineralization in Hyp bone, Mol. Endocrinol., 23, 1505, 10.1210/me.2009-0085
Liu, 2006, Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D, J. Am. Soc. Nephrol., 17, 1305, 10.1681/ASN.2005111185
Liu, 2008, FGFR3 and FGFR4 do not mediate renal effects of FGF23, J. Am. Soc. Nephrol., 19, 2342, 10.1681/ASN.2007121301
Liu, 2006, Pathogenic role of Fgf23 in Hyp mice, Am. J. Physiol. Endocrinol. Metab., 291, E38, 10.1152/ajpendo.00008.2006
Mirams, 2004, Bone as a source of FGF23: regulation by phosphate?, Bone, 35, 1192, 10.1016/j.bone.2004.06.014
Mirza, 2011, Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individuals, Arterioscler. Thromb. Vasc. Biol., 31, 219, 10.1161/ATVBAHA.110.214619
Moe, 2006, Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO), Kidney Int., 69, 1945, 10.1038/sj.ki.5000414
Moe, 2010, Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease, Clin. J. Am. Soc. Nephrol., 6, 257, 10.2215/CJN.05040610
Nagano, 2006, Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats, Kidney Int., 69, 531, 10.1038/sj.ki.5000020
Nishida, 2006, Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men, Kidney Int., 70, 2141, 10.1038/sj.ki.5002000
O'Neill, 2010, Recent progress in the treatment of vascular calcification, Kidney Int., 78, 1232, 10.1038/ki.2010.334
Oliveira, 2010, Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy?, Clin. J. Am. Soc. Nephrol., 5, 286, 10.2215/CJN.05420709
Perwad, 2005, Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice, Endocrinology, 146, 5358, 10.1210/en.2005-0777
Quarles, 2011, The bone and beyond: ‘dem bones’ are made for more than walking, Nat. Med., 17, 428, 10.1038/nm0411-428
Quarles, 2008, Endocrine functions of bone in mineral metabolism regulation, J. Clin. Invest., 118, 3820, 10.1172/JCI36479
Quarles, 2003, Evidence for a bone-kidney axis regulating phosphate homeostasis, J. Clin. Invest., 112, 642, 10.1172/JCI200319687
Quarles, 1992, Effects of etidronate-mediated suppression of bone remodeling on aluminum-induced de novo bone formation, Endocrinology, 131, 122, 10.1210/en.131.1.122
Razzaque, 2005, FGF-23, vitamin D and calcification: the unholy triad, Nephrol. Dial. Transplant., 20, 2032, 10.1093/ndt/gfh991
Rhee, 2009, FGF23 gene expression is upregulated by PTH receptor activation in osteocytes in vitr and in vivo: a parathyroid-bone link influencing the endocrine function of osteocytes, A09001860
Rhee, 2010, PTH receptor signaling in osteocytes governs periosteal bone formation and intra-cortical remodeling, J. Bone Miner. Res., 26, 1035, 10.1002/jbmr.304
Rhee, 2011, Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo, Bone, 49, 636, 10.1016/j.bone.2011.06.025
Riminucci, 2003, FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting, J. Clin. Invest., 112, 683, 10.1172/JCI18399
Rosen, 2011, Clinical practice. Vitamin D insufficiency, N. Engl. J. Med., 364, 248, 10.1056/NEJMcp1009570
Rowe, 2004, MEPE has the properties of an osteoblastic phosphatonin and minhibin, Bone, 34, 303, 10.1016/j.bone.2003.10.005
Saito, 2005, Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo, J. Biol. Chem., 280, 2543, 10.1074/jbc.M408903200
Saji, 2010, Fibroblast growth factor 23 production in bone is directly regulated by 1{alpha},25-dihydroxyvitamin D, but not PTH, Am. J. Physiol. Renal Physiol., 299, F1212, 10.1152/ajprenal.00169.2010
Saji, 2009, Regulation of fibroblast growth factor 23 production in bone in uremic rats, Nephron Physiol., 111, 59, 10.1159/000210389
Samadfam, 2009, Bone formation regulates circulating concentrations of fibroblast growth factor 23, Endocrinology, 150, 4835, 10.1210/en.2009-0472
Sato, 2004, Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism, Am. J. Kidney Dis., 44, 481, 10.1016/S0272-6386(04)00817-0
Shimada, 2004, Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism, J. Clin. Invest., 113, 561, 10.1172/JCI200419081
Shimada, 2001, Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia, Proc. Natl. Acad. Sci. U. S. A., 98, 6500, 10.1073/pnas.101545198
Shimada, 2004, Angiogenesis and vasculogenesis are impaired in the precocious-aging klotho mouse, Circulation, 110, 1148, 10.1161/01.CIR.0000139854.74847.99
Shimada, 2005, Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism, Am. J. Physiol. Renal Physiol., 289, F1088, 10.1152/ajprenal.00474.2004
Shore, 2002, Paternally inherited inactivating mutations of the GNAS1 gene in progressive osseous heteroplasia, N. Engl. J. Med., 346, 99, 10.1056/NEJMoa011262
Sitara, 2004, Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice, Matrix Biol., 23, 421, 10.1016/j.matbio.2004.09.007
Sitara, 2006, Genetic ablation of vitamin D activation pathway reverses biochemical and skeletal anomalies in Fgf-23-null animals, Am. J. Pathol., 169, 2161, 10.2353/ajpath.2006.060329
Stubbs, 2007, Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease, Semin. Dial., 20, 302, 10.1111/j.1525-139X.2007.00308.x
Stubbs, 2009, Cholecalciferol supplementation alters calcitriol-responsive monocyte proteins and decreases inflammatory cytokines in ESRD, J. Am. Soc. Nephrol.
Stubbs, 2009, Fibroblast growth factor 23: uremic toxin or innocent bystander in chronic kidney disease?, Nephrol. News Issues, 23, 36
Takeshita, 2004, Sinoatrial node dysfunction and early unexpected death of mice with a defect of klotho gene expression, Circulation, 109, 1776, 10.1161/01.CIR.0000124224.48962.32
Tebben, 2004, Fibroblast growth factor 23, parathyroid hormone, and 1alpha,25-dihydroxyvitamin D in surgically treated primary hyperparathyroidism, Mayo Clin. Proc., 79, 1508, 10.4065/79.12.1508
Tentori, 2006, Mortality risk among hemodialysis patients receiving different vitamin D analogs, Kidney Int., 70, 1858, 10.1038/sj.ki.5001868
Tomiyama, 2010, Relevant use of Klotho in FGF19 subfamily signaling system in vivo, Proc. Natl. Acad. Sci. U. S. A., 107, 1666, 10.1073/pnas.0913986107
Tsuji, 2010, Leptin stimulates fibroblast growth factor 23 expression in bone and suppresses renal 1alpha,25-dihydroxyvitamin D(3) synthesis in leptin-deficient ob/ob mice, J. Bone Miner. Res., 25, 1711, 10.1002/jbmr.65
Urakawa, 2006, Klotho converts canonical FGF receptor into a specific receptor for FGF23, Nature, 444, 770, 10.1038/nature05315
Uzum, 2010, Effects of vitamin D replacement therapy on serum FGF23 concentrations in vitamin D-deficient women in short term, Eur. J. Endocrinol., 163, 825, 10.1530/EJE-10-0591
van de Graaf, 2004, Regulation of the epithelial Ca2+ channels TRPV5 and TRPV6 by 1alpha,25-dihydroxy Vitamin D3 and dietary Ca2+, J. Steroid Biochem. Mol. Biol., 89–90, 303, 10.1016/j.jsbmb.2004.03.029
van Husen, 2010, Fibroblast growth factor 23 and bone metabolism in children with chronic kidney disease, Kidney Int., 78, 200, 10.1038/ki.2010.107
Vervloet, 2010, Effects of dietary phosphate and calcium intake on Fibroblast Growth Factor-23, Clin. J. Am. Soc. Nephrol.
Weber, 2003, Serum FGF23 levels in normal and disordered phosphorus homeostasis, J. Bone Miner. Res., 18, 1227, 10.1359/jbmr.2003.18.7.1227
Wetmore, 2009, Effects of cinacalcet and concurrent low-dose vitamin D on FGF23 levels in ESRD, Clin. J. Am. Soc. Nephrol.
Wetmore, 2009, Calcimimetics or vitamin D analogs for suppressing parathyroid hormone in end-stage renal disease: time for a paradigm shift?, Nat. Clin. Pract. Nephrol., 5, 24, 10.1038/ncpneph0977
Wetmore, 2011, Elevated FGF23 levels are associated with impaired calcium-mediated suppression of PTH in ESRD, J. Clin. Endocrinol. Metab., 96, E57, 10.1210/jc.2010-1277
White, 2001, Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23, Kidney Int., 60, 2079, 10.1046/j.1523-1755.2001.00064.x
Wolf, 2010, Forging forward with 10 burning questions on FGF23 in kidney disease, J. Am. Soc. Nephrol., 21, 1427, 10.1681/ASN.2009121293
Yamashita, 2000, Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain, Biochem. Biophys. Res. Commun., 277, 494, 10.1006/bbrc.2000.3696
Young, 2004, Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS), Am. J. Kidney Dis., 44, 34, 10.1016/S0272-6386(04)01103-5